CRISPR/Cas9-mediated Editing of Human ?-globin Gene in Human Cells: A Commentary on the Research Ethics

  • Norman K. Swazo Department of History and Philosophy North South University
Keywords: CRISPR/Cas9, human germ line modification, ethics, China, gene-editing technology

Abstract

Recently, Chinese researchers published the results of their research using a gene-editing technology on abnormal human zygotes.  The research team believes this research has prospective clinical application, viz., for gene therapy for ?-thalassemia, a white blood cell disorder, and plan to persist with further studies, despite technical problems in this experiment.  The research has elicited international criticism from both scientific and bioethics domains, because it innovates beyond the current global consensus against human germ line modification.  This paper comments on some ethical issues presented by the research report and concludes that, under present circumstances, the Chinese research team did not meet a standard of scientific responsibility.

Bangladesh Journal of Bioethics 2015 Vol.6 (1):22-26.

 

Downloads

Download data is not yet available.
Abstract
1102
PDF
1059

Author Biography

Norman K. Swazo, Department of History and Philosophy North South University
Department of History and Philosophy
Published
2015-08-01
How to Cite
Swazo, N. K. (2015). CRISPR/Cas9-mediated Editing of Human ?-globin Gene in Human Cells: A Commentary on the Research Ethics. Bangladesh Journal of Bioethics, 6(1), 22-26. https://doi.org/10.3329/bioethics.v6i1.24402
Section
Commentary